| Ann M Hefter, AGACNP-BC, MSN, BSN | |
|
1818 N Meade St, Appleton, WI 54911-3454 | |
| (920) 731-8900 | |
| Not Available |
| Full Name | Ann M Hefter |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 1818 N Meade St, Appleton, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003584145 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 11169 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Ne Wisconsin - St Elizabeth Campus | Appleton, WI | Hospital |
| Thedacare Regional Medical Center - Appleton Inc | Appleton, WI | Hospital |
| Thedacare Regional Med Ctr - Neenah | Neenah, WI | Hospital |
| Thedacare Medical Center-waupaca | Waupaca, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ascension Medical Group-fox Valley Wisconsin Inc | 0244142420 | 258 |
| Thedacare Incorporated | 1759294887 | 493 |
News Archive
The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squamous cell carcinoma or locally advanced CSCC who are not candidates for curative surgery or curative radiation.
NicOx S.A. today announced that a New Drug Application (NDA) for naproxcinod has been submitted to the United States Food and Drug Administration (FDA), seeking approval for an indication for the relief of the signs and symptoms of osteoarthritis (OA). The NDA file contains data from three large pivotal phase 3 studies, all of which met their co-primary efficacy endpoints. NicOx plans to submit a Marketing Authorization Application (MAA) for naproxcinod to the European Medicines Agency (EMEA) in Q4 2009.
The age at first birth in Malawi has remained constant from 1992 to 2010, despite expanded access to education for girls. Social demographer Monica Grant explores this finding in a new Population Development and Review paper, noting that it does not imply that women would have been better off in the absence of recent education policies.
The high-dose flu vaccine appeared to be more effective at preventing post-influenza deaths among older adults than the standard-dose vaccine, at least during a more severe flu season, according to a large new study of Medicare beneficiaries published in The Journal of Infectious Diseases.
› Verified 1 days ago
| Entity Name | Ascension Medical Group-fox Valley Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730126392 PECOS PAC ID: 0244142420 Enrollment ID: O20031105000351 |
News Archive
The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squamous cell carcinoma or locally advanced CSCC who are not candidates for curative surgery or curative radiation.
NicOx S.A. today announced that a New Drug Application (NDA) for naproxcinod has been submitted to the United States Food and Drug Administration (FDA), seeking approval for an indication for the relief of the signs and symptoms of osteoarthritis (OA). The NDA file contains data from three large pivotal phase 3 studies, all of which met their co-primary efficacy endpoints. NicOx plans to submit a Marketing Authorization Application (MAA) for naproxcinod to the European Medicines Agency (EMEA) in Q4 2009.
The age at first birth in Malawi has remained constant from 1992 to 2010, despite expanded access to education for girls. Social demographer Monica Grant explores this finding in a new Population Development and Review paper, noting that it does not imply that women would have been better off in the absence of recent education policies.
The high-dose flu vaccine appeared to be more effective at preventing post-influenza deaths among older adults than the standard-dose vaccine, at least during a more severe flu season, according to a large new study of Medicare beneficiaries published in The Journal of Infectious Diseases.
› Verified 1 days ago
| Entity Name | Thedacare Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376656959 PECOS PAC ID: 1759294887 Enrollment ID: O20031106000088 |
News Archive
The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squamous cell carcinoma or locally advanced CSCC who are not candidates for curative surgery or curative radiation.
NicOx S.A. today announced that a New Drug Application (NDA) for naproxcinod has been submitted to the United States Food and Drug Administration (FDA), seeking approval for an indication for the relief of the signs and symptoms of osteoarthritis (OA). The NDA file contains data from three large pivotal phase 3 studies, all of which met their co-primary efficacy endpoints. NicOx plans to submit a Marketing Authorization Application (MAA) for naproxcinod to the European Medicines Agency (EMEA) in Q4 2009.
The age at first birth in Malawi has remained constant from 1992 to 2010, despite expanded access to education for girls. Social demographer Monica Grant explores this finding in a new Population Development and Review paper, noting that it does not imply that women would have been better off in the absence of recent education policies.
The high-dose flu vaccine appeared to be more effective at preventing post-influenza deaths among older adults than the standard-dose vaccine, at least during a more severe flu season, according to a large new study of Medicare beneficiaries published in The Journal of Infectious Diseases.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ann M Hefter, AGACNP-BC, MSN, BSN 1818 N Meade St, Appleton, WI 54911-3454 Ph: (920) 731-8900 | Ann M Hefter, AGACNP-BC, MSN, BSN 1818 N Meade St, Appleton, WI 54911-3454 Ph: (920) 731-8900 |
News Archive
The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squamous cell carcinoma or locally advanced CSCC who are not candidates for curative surgery or curative radiation.
NicOx S.A. today announced that a New Drug Application (NDA) for naproxcinod has been submitted to the United States Food and Drug Administration (FDA), seeking approval for an indication for the relief of the signs and symptoms of osteoarthritis (OA). The NDA file contains data from three large pivotal phase 3 studies, all of which met their co-primary efficacy endpoints. NicOx plans to submit a Marketing Authorization Application (MAA) for naproxcinod to the European Medicines Agency (EMEA) in Q4 2009.
The age at first birth in Malawi has remained constant from 1992 to 2010, despite expanded access to education for girls. Social demographer Monica Grant explores this finding in a new Population Development and Review paper, noting that it does not imply that women would have been better off in the absence of recent education policies.
The high-dose flu vaccine appeared to be more effective at preventing post-influenza deaths among older adults than the standard-dose vaccine, at least during a more severe flu season, according to a large new study of Medicare beneficiaries published in The Journal of Infectious Diseases.
› Verified 1 days ago
Dessia J Laxton-reinke, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1818 N Meade St, Appleton, WI 54911 Phone: 920-731-8900 Fax: 920-738-5369 | |
Katie Geiser, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5045 W Grande Market Dr, Appleton, WI 54913 Phone: 920-886-9380 | |
Lisa Valiquette, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2500 E Capitol Dr, Appleton, WI 54911 Phone: 920-738-4600 Fax: 920-738-4792 | |
Kimberly A Romenesko, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1818 N Meade St, Appleton, WI 54911 Phone: 920-735-7645 Fax: 920-735-7618 | |
Steven R Hamel, APN FP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3925 N Gateway Dr, Appleton, WI 54913 Phone: 920-830-6877 | |
Ms. Zoua Yang, APNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1818 N Meade St, Appleton, WI 54911 Phone: 920-731-4101 |